Detalhe da pesquisa
1.
Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.
Eur Heart J
; 43(23): 2224-2234, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35393622
2.
A global perspective of racial differences and outcomes in patients presenting with acute heart failure.
Am Heart J
; 243: 11-14, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516969
3.
Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial.
Diabetologia
; 58(9): 2020-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26067186
4.
Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.
Diabetologia
; 57(7): 1304-7, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24682379
5.
Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.
Eur J Heart Fail
; 25(1): 43-51, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196060
6.
Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
Eur J Heart Fail
; 25(6): 818-828, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974770
7.
Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study.
Lancet Glob Health
; 11(12): e1874-e1884, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37973338
8.
Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry.
JACC Heart Fail
; 11(9): 1262-1271, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678961
9.
Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia.
Eur J Prev Cardiol
; 29(9): 1361-1368, 2022 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175352
10.
Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.
Eur J Heart Fail
; 24(4): 645-652, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064730
11.
Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).
Eur J Heart Fail
; 24(6): 1020-1029, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429091
12.
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF.
JACC Heart Fail
; 9(5): 349-359, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33839078
13.
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.
Lancet Glob Health
; 8(3): e411-e422, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087174
14.
Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure.
JAMA Cardiol
; 5(4): 401-410, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31913404
15.
Experimental infection of rodent mammals for fungal virulence testing.
Methods Mol Biol
; 470: 141-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19089382
16.
Characterization of the influence of vildagliptin on model-assessed -cell function in patients with type 2 diabetes and mild hyperglycemia.
J Clin Endocrinol Metab
; 93(1): 103-9, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17925336
17.
Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
Diabetes Care
; 30(2): 217-23, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17259484
18.
Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet.
Vasc Health Risk Manag
; 4(3): 481-92, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18827867
19.
The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.
J Clin Endocrinol Metab
; 92(11): 4165-71, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17698900
20.
Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes.
Diabetes Res Clin Pract
; 76(1): 132-8, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17223217